Literature DB >> 8294863

Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.

T R Kollmann1, M Pettoello-Mantovani, X Zhuang, A Kim, M Hachamovitch, P Smarnworawong, A Rubinstein, H Goldstein.   

Abstract

A small animal model that could be infected with human immunodeficiency virus 1 (HIV-1) after peripheral inoculation would greatly facilitate the study of the pathophysiology of acute HIV-1 infection. The utility of SCID mice implanted with human fetal thymus and liver (SCID-hu mice) for studying peripheral HIV-1 infection in vivo has been hampered by the requirement for direct intraimplant injection of HIV-1 and the continued restriction of the resultant HIV-1 infection to the human thymus and liver (hu-thy/liv) implant. This may have been due to the very low numbers of human T cells present in the SCID-hu mouse peripheral lymphoid compartment. Since the degree of the peripheral reconstitution of SCID-hu mice with human T cells may be a function of the hu-thy/liv implant size, we increased the quantity of hu-thy/liv tissue implanted under the renal capsule and implanted hu-thy/liv tissue under the capsules of both kidneys. This resulted in SCID-hu mice in which significant numbers of human T cells were detected in the peripheral blood, spleens, and lymph nodes. After intraimplant injection of HIV-1 into these modified SCID-hu mice, significant HIV-1 infection was detected by quantitative coculture not only in the hu-thy/liv implant, but also in the spleen and peripheral blood. This indicated that HIV-1 infection can spread from the thymus to the peripheral lymphoid compartment. More importantly, a similar degree of infection of the hu-thy/liv implant and peripheral lymphoid compartment occurred after peripheral intraperitoneal inoculation with HIV-1. Active viral replication was indicated by the detection of HIV-1 gag DNA, HIV-1 gag RNA, and spliced tat/rev RNA in the hu-thy/liv implants, peripheral blood mononuclear cells (PBMC), spleens, and lymph nodes of these HIV-1-infected SCID-hu mice. As a first step in using our modified SCID-hu mouse model to investigate the pathophysiological consequences of HIV-1 infection, the effect of HIV-1 infection on the expression of human cytokines shown to enhance HIV-1 replication was examined. Significantly more of the HIV-1-infected SCID-hu mice expressed mRNA for human tumor necrosis factors alpha and beta, and interleukin 2 in their spleens, lymph nodes, and PBMC than did uninfected SCID-hu mice. This suggested that HIV-1 infection in vivo can stimulate the expression of cytokine mRNA by human T cells.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294863      PMCID: PMC2191362          DOI: 10.1084/jem.179.2.513

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Frequent and early in utero HIV-1 infection.

Authors:  V Courgnaud; F Lauré; A Brossard; C Bignozzi; A Goudeau; F Barin; C Bréchot
Journal:  AIDS Res Hum Retroviruses       Date:  1991-03       Impact factor: 2.205

2.  Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion.

Authors:  S M Schnittman; S M Denning; J J Greenhouse; J S Justement; M Baseler; J Kurtzberg; B F Haynes; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester.

Authors:  H Mano; J C Chermann
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

4.  HIV in pregnant women and their offspring: evidence for late transmission.

Authors:  A Ehrnst; S Lindgren; M Dictor; B Johansson; A Sönnerborg; J Czajkowski; G Sundin; A B Bohlin
Journal:  Lancet       Date:  1991-07-27       Impact factor: 79.321

5.  Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes.

Authors:  B K English; W M Weaver; C B Wilson
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

6.  HIV induces thymus depletion in vivo.

Authors:  M L Bonyhadi; L Rabin; S Salimi; D A Brown; J Kosek; J M McCune; H Kaneshima
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

7.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

8.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

9.  Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.

Authors:  J F Krowka; S Sarin; R Namikawa; J M McCune; H Kaneshima
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

10.  The SCID-hu mouse as a model for HIV-1 infection.

Authors:  G M Aldrovandi; G Feuer; L Gao; B Jamieson; M Kristeva; I S Chen; J A Zack
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

View more
  21 in total

1.  High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo.

Authors:  B D Jamieson; C H Uittenbogaart; I Schmid; J A Zack
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function.

Authors:  Gregory D Sempowski; Charles B Hicks; Joseph J Eron; John A Bartlett; Laura P Hale; Guido Ferrari; Lloyd J Edwards; Susan Fiscus; Barton F Haynes
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

3.  Inhibition of human lymphocyte function by organic solvents.

Authors:  A S Shoker; M A Murabit; F F Georges; L F Qualtiere; H G Deneer; K Prasad
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

4.  Analysis of the in vitro effect of exogenous nitric oxide on human lymphocytes.

Authors:  A S Shoker; H Yang; M A Murabit; H Jamil; A al-Ghoul; K Okasha
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

5.  Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.

Authors:  M Pettoello-Mantovani; T R Kollmann; C Raker; A Kim; S Yurasov; R Tudor; H Wiltshire; H Goldstein
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

6.  HIV-1 pathogenesis and therapeutic intervention in the SCID-hu Thy/Liv mouse: a model for primary HIV-1 infection in the human thymus.

Authors: 
Journal:  Rev Med Virol       Date:  1997-09       Impact factor: 6.989

Review 7.  Studies of retroviral infection in humanized mice.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Virology       Date:  2015-02-11       Impact factor: 3.616

8.  Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus type 1.

Authors:  A Valentin; G Aldrovandi; A S Zolotukhin; S W Cole; J A Zack; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Authors:  G M Aldrovandi; J A Zack
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 10.  The utilization of humanized mouse models for the study of human retroviral infections.

Authors:  Rachel Van Duyne; Caitlin Pedati; Irene Guendel; Lawrence Carpio; Kylene Kehn-Hall; Mohammed Saifuddin; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-08-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.